Aurinia Pharmaceuticals AUPH Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Rogers CorporationROG

$4M-4.8%

Theravance BiopharmaTBPH

$10.8M-0.9%

Opko HealthOPK

$11.01M+11.0%

Kiniksa Pharmaceuticals International, plcKNSA

$4.01M+59.1%

Mirum Pharmaceuticals, Inc.MIRM

$2.41M+15.6%

ALN

Alnylam PharmaceuticalsALNY

$45.93M-0.4%

FAQ

What is Aurinia Pharmaceuticals's operating lease liabilities (current)?

Aurinia Pharmaceuticals (AUPH) reported operating lease liabilities (current) of $1.71M in Q2 2026.

How has Aurinia Pharmaceuticals's operating lease liabilities (current) changed year-over-year?

Aurinia Pharmaceuticals's operating lease liabilities (current) increased by 62.8% year-over-year, from $1.05M to $1.71M.

What is the long-term trend for Aurinia Pharmaceuticals's operating lease liabilities (current)?

Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's operating lease liabilities (current) has grown at a 6.2% compound annual growth rate (CAGR), from $788K to $1.07M.

What does operating lease liabilities (current) mean?

The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.